Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs recombinant FSH for follicular recruitment in women with polycystic ovaries undergoing IVM
2017-002571-25Phase 3Completed
- Sponsor
- UZ Brussel
- Start
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in polycystic ovary syndrome (PCOS) and infertility comparing Elonva arm with Puregon arm (2 arms). Primary endpoint: Number of immature oocytes available for in vitro maturation. Started Aug 2017; status: completed.
02
Drugs
corifollitropin alfafollitropin beta
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on 2017-002571-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002571-25.